New scan could replace invasive biopsies for cancer treatment decisions
NCT ID NCT05742269
Summary
This study aimed to test a new type of whole-body scan to see if it could better predict which patients with advanced triple-negative breast cancer would benefit from a specific immunotherapy. The scan uses a radioactive tracer to find a protein target in tumors, potentially offering a clearer picture than a standard tissue biopsy. The trial was terminated early after enrolling only 3 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Karolinska University Hospital
Stockholm, 171 76, Sweden
Conditions
Explore the condition pages connected to this study.